Compounds > porfiromycin
Page last updated: 2024-08-21

porfiromycin and Carcinoma, Squamous Cell

porfiromycin has been researched along with Carcinoma, Squamous Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, EI; Fischer, DB; Fischer, JJ; Haffty, BG; Papac, RJ; Rockwell, S; Ross, DA; Sartorelli, AC; Sasaki, CT; Son, YH; Wilson, LD1
Fischer, D; Fischer, JJ; Haffty, BG; Papac, R; Rockwell, S; Ross, D; Sartorelli, AC; Sasaki, CT; Son, YH; Wilson, LD1
Lane, M; Panettiere, FJ; Talley, RW; Torres, J1
al-Sarraf, M; Izbicki, R; Reed, ML; Vaitkevicius, VK; Vaughn, CB1

Trials

4 trial(s) available for porfiromycin and Carcinoma, Squamous Cell

ArticleYear
Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial.
    International journal of radiation oncology, biology, physics, 2005, Jan-01, Volume: 61, Issue:1

    Topics: Analysis of Variance; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Mitomycin; Porfiromycin; Prospective Studies; Radiotherapy Dosage; Statistics, Nonparametric; Thrombocytopenia

2005
Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Radiation oncology investigations, 1997, Volume: 5, Issue:5

    Topics: Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose Fractionation, Radiation; Follow-Up Studies; Head and Neck Neoplasms; Humans; Mitomycin; Porfiromycin; Survival Rate; Time Factors

1997
Porfiromycin in the management of epidermoid and transitional cell cancer: a phase II study.
    Cancer treatment reports, 1976, Volume: 60, Issue:7

    Topics: Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Clinical Trials as Topic; Female; Head and Neck Neoplasms; Humans; Leukopenia; Lung Neoplasms; Porfiromycin; Thrombocytopenia; Ureteral Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Vulvar Neoplasms

1976
Further clinical trials with porfiromycin (NSC-56410) (large intermittent doses).
    Cancer chemotherapy reports, 1972, Volume: 56, Issue:5

    Topics: Adenocarcinoma; Adult; Anemia; Astrocytoma; Blood Cell Count; Blood Platelets; Carcinoma; Carcinoma, Squamous Cell; Child; Clinical Trials as Topic; Cystadenoma; Female; Humans; Leukocyte Count; Neoplasms; Osteosarcoma; Porfiromycin; Rhabdomyosarcoma

1972